Coverage
-
April 17, 2012
An order in a patent dispute barring Lupin Ltd. from selling its generic version of the diabetes drug Fortamet once again will be scrutinized by the Federal Circuit on Wednesday, two months after the appeals court lifted the same preliminary injunction.
1 other articles on this case.
View all »